Role of antibiotic line locks in the prevention of tunnelled haemodialysis catheter infection: a double-blind, randomised controlled trial
ISRCTN | ISRCTN32633497 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN32633497 |
Secondary identifying numbers | 08/05 |
- Submission date
- 07/06/2004
- Registration date
- 26/09/2005
- Last edited
- 05/02/2013
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Peter McClelland
Scientific
Scientific
Arrowe Park Hospital
Liverpool
CH49 5PE
United Kingdom
Study information
Study design | Randomised double blind controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Prevention |
Scientific title | |
Study objectives | The null hypothesis to be tested is that antibiotic line locks will not reduce the incidence of catheter related blood stream infection compared with the standard practice of catheter filling with heparin alone. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Haemodialysis catheter related sepsis |
Intervention | Control group will receive usual heparin line locks between dialysis sessions. Intervention group will receive a line lock containing heparin, vancomycin and gentamicin. |
Intervention type | Other |
Primary outcome measure | The time in days from insertion of tunnelled haemodialysis catheter (THDC) to first catheter related infection (CRI). CRI will be diagnosed by a combination of clinical suspicion, raised temperature, blood tests (white cell count and inflammatory markers) and the results of blood cultures from the tunnelled haemodialysis catheter (THDC) and from a peripheral vein. |
Secondary outcome measures | 1. Mean haemoglobin concentration 2. Mean erythropoietin dose adjusted for body mass 3. Mean serum albumin concentration 4. Mean number of days in hospital per annum 5. Mean number of hospital admissions per annum |
Overall study start date | 01/08/2004 |
Completion date | 01/08/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 80 |
Key inclusion criteria | All patients requiring insertion of a tunnelled haemodialysis catheter (THDC) for haemodialysis. |
Key exclusion criteria | 1. Patients on prolonged courses of antibiotics (oral or parenteral) i.e. for greater than 2 weeks. (This may reduce the incidence of CRI and therefore confound the results). 2. Patients with a known allergy to vancomycin or gentamicin 3. Patients known to suffer from heparin induced thrombocytopenia 4. Patients who are pregnant or plan to become pregnant. (Vancomycin and gentamicin are potentially toxic to the fetus). 5. An inability to provide informed consent to participation in the study |
Date of first enrolment | 01/08/2004 |
Date of final enrolment | 01/08/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Arrowe Park Hospital
Liverpool
CH49 5PE
United Kingdom
CH49 5PE
United Kingdom
Sponsor information
Wirral Hospitals NHS Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
Arrowe Park Hospital
Liverpool
CH49 5PE
England
United Kingdom
https://ror.org/05cv4zg26 |
Funders
Funder type
Hospital/treatment centre
Funded within our department
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |